Bing Xu

3.7k total citations
95 papers, 2.7k citations indexed

About

Bing Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Bing Xu has authored 95 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 24 papers in Cancer Research and 19 papers in Immunology. Recurrent topics in Bing Xu's work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Bing Xu is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Bing Xu collaborates with scholars based in China, United States and Australia. Bing Xu's co-authors include Jie Liang, Yi Chu, Kaichun Wu, Mingzuo Jiang, Jibao Lu, Hefeng Cheng, Xiaoyan Qin, Baibiao Huang, Xiaoyang Zhang and Ying Dai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bing Xu

91 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Xu China 30 1.5k 793 507 284 253 95 2.7k
Lijing Wang China 30 1.3k 0.9× 529 0.7× 434 0.9× 397 1.4× 208 0.8× 110 2.6k
Fei Pan China 25 2.1k 1.4× 832 1.0× 220 0.4× 500 1.8× 369 1.5× 103 3.3k
Fei Gao China 36 1.2k 0.8× 393 0.5× 879 1.7× 469 1.7× 267 1.1× 136 4.0k
Yunsheng Xu China 27 1.1k 0.7× 351 0.4× 457 0.9× 261 0.9× 181 0.7× 70 2.6k
Jeong Kon Seo South Korea 25 1.3k 0.9× 243 0.3× 269 0.5× 297 1.0× 205 0.8× 73 2.6k
Ping Xue China 24 1.1k 0.7× 685 0.9× 302 0.6× 263 0.9× 403 1.6× 51 2.8k
Rui Xie China 39 2.3k 1.5× 1.0k 1.3× 582 1.1× 704 2.5× 526 2.1× 146 4.9k
Xuedong Fang China 30 1.3k 0.9× 438 0.6× 213 0.4× 413 1.5× 188 0.7× 85 2.5k
Gaofeng Liang China 25 1.6k 1.1× 935 1.2× 183 0.4× 218 0.8× 126 0.5× 118 2.7k
Jiaming Zhang China 27 1.1k 0.7× 436 0.5× 164 0.3× 224 0.8× 146 0.6× 145 2.4k

Countries citing papers authored by Bing Xu

Since Specialization
Citations

This map shows the geographic impact of Bing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xu more than expected).

Fields of papers citing papers by Bing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xu. The network helps show where Bing Xu may publish in the future.

Co-authorship network of co-authors of Bing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xu. A scholar is included among the top collaborators of Bing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xu. Bing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Tianming, Rui Fang, Jing Ding, et al.. (2024). Melatonin ameliorates multiorgan injuries induced by severe acute pancreatitis in mice by regulating the Nrf2 signaling pathway. European Journal of Pharmacology. 975. 176646–176646. 4 indexed citations
2.
Xu, Bing, et al.. (2024). The role and mechanism of TXNDC5 in disease progression. Frontiers in Immunology. 15. 5 indexed citations
3.
Liu, Wei, et al.. (2023). Rapid synthesis of two photoluminescent pyridinium manganese-based halides by an anti-solvent method. Journal of Alloys and Compounds. 968. 172173–172173. 3 indexed citations
4.
Luo, Tingting, Tianming Zhao, Chunyan Chen, et al.. (2023). Hepatocyte DDX3X protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress. Cell Death and Disease. 14(7). 400–400. 17 indexed citations
5.
Xu, Bing, Yi Sui, Hui Li, et al.. (2023). Cytohesin-4 Upregulation in Glioma-Associated M2 Macrophages Is Correlated with Pyroptosis and Poor Prognosis. Journal of Molecular Neuroscience. 73(2-3). 143–158. 8 indexed citations
6.
Han, Yuying, Xiaoliang Gao, Nan Wu, et al.. (2022). Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death and Disease. 13(8). 742–742. 54 indexed citations
7.
Liao, Yilan, Chunlin Li, Changfa Xia, et al.. (2020). Spatial distribution of esophageal cancer mortality in China: a machine learning approach. International Health. 13(1). 70–79. 8 indexed citations
8.
Qin, Qin, et al.. (2020). DNA methylation data‐based prognosis‐subtype distinctions in patients with esophageal carcinoma by bioinformatic studies. Journal of Cellular Physiology. 236(3). 2126–2138. 6 indexed citations
9.
Chen, Hui, Bing Xu, Jing Lü, et al.. (2020). The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma. Gene. 768. 145261–145261. 12 indexed citations
10.
Liu, Bingqi, Guangsheng Yang, Xin Wang, et al.. (2020). CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR. Journal of Cellular Physiology. 235(10). 6929–6941. 68 indexed citations
11.
Chen, Fangyu, Li Chu, Jie Li, et al.. (2020). Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells. Thoracic Cancer. 11(3). 570–580. 27 indexed citations
12.
Li, Xin, Lihua Liu, Bing Xu, et al.. (2020). Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions. Pharmacology Research & Perspectives. 8(2). e00593–e00593. 7 indexed citations
13.
14.
Chu, Yi, Mingzuo Jiang, Nan Wu, et al.. (2020). O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 10(21). 9830–9842. 49 indexed citations
15.
Wu, Nan, Mingzuo Jiang, Haiming Liu, et al.. (2020). LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death and Differentiation. 28(1). 219–232. 125 indexed citations
16.
Han, Yuying, Nan Wu, Mingzuo Jiang, et al.. (2019). Long non‐coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐29c‐3p in gastric cancer. Cell Proliferation. 52(6). e12678–e12678. 53 indexed citations
17.
Tian, Tian, Yongtao Yang, Bing Xu, et al.. (2019). Pigment epithelium-derived factor alleviates depressive-like behaviors in mice by modulating adult hippocampal synaptic growth and Wnt pathway. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 98. 109792–109792. 15 indexed citations
18.
Wang, Min, Cong Liang, Hao Hu, et al.. (2016). Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Scientific Reports. 6(1). 30696–30696. 96 indexed citations
19.
Xu, Bing, Xiaowei Li, Jipeng Yin, et al.. (2015). Evaluation of 68Ga-Labeled MG7 Antibody: A Targeted Probe for PET/CT Imaging of Gastric Cancer. Scientific Reports. 5(1). 8626–8626. 19 indexed citations
20.
Xu, Bing, Wenxing Wang, Haiyang Guo, et al.. (2014). Oxidative stress preferentially induces a subtype of micronuclei and mediates the genomic instability caused by p53 dysfunction. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 770. 1–8. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026